MIM
TARO

MetLife Investment Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

MetLife Investment Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,336
Closed -$184K – 2939
2024
Q1 		$184K Hold
4,336
– – ﹤0.01% 2245
2023
Q4 		$181K Buy
+4,336
New +$160K ﹤0.01% 2294
2023
Q3 		– Sell
-4,336
Closed -$164K – 2998
2023
Q2 		$164K Buy
+4,336
New +$136K ﹤0.01% 2394

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

MetLife Investment Management's TARO Position: Q2 2024 in Review

MetLife Investment Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 4,336 shares — an estimated $184K sold.

MetLife Investment Management first reported a position in TARO in Q2 2023 and held it in 3 quarters. The position peaked at $184K in Q1 2024. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • MetLife Investment Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • MetLife Investment Management sold 4,336 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $184K.
  • MetLife Investment Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2023 and held it in 3 quarters.
  • MetLife Investment Management's Taro Pharmaceutical Industries Ltd. position peaked at $184K in Q1 2024.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.